Pear Therapeutics, Inc. - Class A Common Stock (NQ:PEAR)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Apr 18, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pear Therapeutics, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Pear Therapeutics and BrightView Health Expand Pilot Program to Provide Prescription Digital Therapeutics for the Treatment of Substance Use Disorders

January 26, 2023

From Pear Therapeutics, Inc.

Via Business Wire

Pear Therapeutics Announces Inclusion of reSET® and reSET-O® on the January 2023 Florida Medicaid Preferred Drug List

January 18, 2023

From Pear Therapeutics, Inc.

Via Business Wire

Pear Therapeutics's Return On Capital Employed Insights ↗

December 26, 2022

Via Benzinga

Pear Therapeutics to Participate in Citi’s BioTech C-Suite Virtual Fireside Chat Series

January 17, 2023

From Pear Therapeutics, Inc.

Via Business Wire

California Department of Health Care Services Awards Contract to Pear Therapeutics to Support the Recovery Incentives Program

January 12, 2023

From Pear Therapeutics, Inc.

Via Business Wire

Pear Therapeutics and COEUS Healthcare Partner to Combat the Addiction Crisis With Prescription Digital Therapeutics

January 10, 2023

From Pear Therapeutics, Inc.

Via Business Wire

Pear Therapeutics and Spero Health to Expand Access to Prescription Digital Therapeutics for People in Recovery Across Multiple Locations and States

January 04, 2023

From Pear Therapeutics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

December 26, 2022

Via Benzinga

Pear Therapeutics Presents Real-World Clinical Data Assessing Engagement and Abstinence in Patients with Alcohol Use Disorders Using reSET® at AAAP

December 15, 2022

From Pear Therapeutics, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Thursday ↗

December 22, 2022

Thursday's session saw 329 companies set new 52-week lows.

Via Benzinga

Pear Therapeutics to Participate in Evercore ISI 5th Annual HealthCONx Conference

November 21, 2022

From Pear Therapeutics, Inc.

Via Business Wire

Why Foresight Autonomous Shares Jumped 33%; Here Are 83 Biggest Movers From Yesterday ↗

November 17, 2022

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares surged 106.3% to close at $0.21 on Wednesday after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process.

Via Benzinga

Why Target Shares Are Trading Lower By 14%? Here Are 56 Stocks Moving In Wednesday's Mid-Day Session ↗

November 16, 2022

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 109% to $0.2115 after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 16, 2022

Via Benzinga

Pear Therapeutics Reports Third Quarter 2022 Results

November 14, 2022

From Pear Therapeutics, Inc.

Via Business Wire

Why Infinity Pharmaceuticals Shares Tumbled Around 38%; Here Are 79 Biggest Movers From Yesterday ↗

November 15, 2022

Gainers Opiant Pharmaceuticals, Inc. (NASDAQ: OPNT) shares surged 113.8% to settle at $20.10 on Monday. Indivior PLC agreed to acquire Opiant Pharmaceuticals for $20.00 per share in cash, plus...

Via Benzinga

Earnings Scheduled For November 14, 2022 ↗

November 14, 2022

Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.

Via Benzinga

Pear Therapeutics to Participate in the BTIG Digital Health Forum

November 10, 2022

From Pear Therapeutics, Inc.

Via Business Wire

Pear Therapeutics Presents Real-World Data Showing Reduction in Healthcare Resource Utilization and Associated Costs in Adults Using Somryst® at ISPOR Europe

November 07, 2022

From Pear Therapeutics, Inc.

Via Business Wire

State of Wisconsin to Provide Access to Prescription Digital Therapeutics to Help Local Communities Fight Against Addiction Crisis

November 03, 2022

From Pear Therapeutics, Inc.

Via Business Wire

Pear Therapeutics to Participate in the Credit Suisse 31st Annual Healthcare Conference

November 01, 2022

From Pear Therapeutics, Inc.

Via Business Wire

Pear Therapeutics to Issue Third Quarter 2022 Financial Results on Monday, November 14, 2022

October 31, 2022

From Pear Therapeutics, Inc.

Via Business Wire

Avis Budget, Scholastic And Other Big Gainers From Monday ↗

October 25, 2022

U.S. stocks closed higher on Monday, with the Dow Jones gaining over 400 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Pear Therapeutics Announces Publication of Real-World Data Showing High Rates of Engagement, Retention and Abstinence with reSET®

October 24, 2022

From Pear Therapeutics, Inc.

Via Business Wire

Netflix, Intuitive Surgical And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

October 19, 2022

U.S. stock futures traded slightly higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

October 19, 2022

Good morning, investors! We're starting off Wednesday with a breakdown of the biggest pre-market stock movers this morning!

Via InvestorPlace

Why Olaplex Holdings Shares Are Trading Lower By 42%; Here Are 27 Stocks Moving Premarket ↗

October 19, 2022

Gainers SenesTech, Inc. (NASDAQ: SNES) shares rose 65.8% to $0.3847 in pre-market trading after declining over 3% on Tuesday.

Via Benzinga

Pear Therapeutics to Participate in LifeSci Partners HealthTech Symposium

September 13, 2022

From Pear Therapeutics, Inc.

Via Business Wire

Pear Therapeutics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

September 07, 2022

From Pear Therapeutics, Inc.

Via Business Wire

Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday ↗

September 12, 2022

Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.